0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global Respiratory Inhalers Market Size, Status and Forecast 2020-2026
Published Date: June 2020
|
Report Code: QYRE-Othe-3U267
Home | Category |Health |Medical Devices & Equipment
respiratory inhalers market

Global Respiratory Inhalers Market Size, Status and Forecast 2020-2026

Code: QYRE-Othe-3U267
Report
June 2020
94 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Respiratory Inhalers Market Overview

The global Respiratory Inhalers market size is projected to reach USD 29220 million by 2026, from USD 28800 million in 2020, at a CAGR of 1.3%% during 2021-2026.

Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. To counter these respiratory disorders, scientists have developed various drugs and devices. Extensive efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder which affects the majority of the patients.

Globally North America is the largest market for Respiratory Inhalers accounting 35.1% of the total market. This large share is majorly due to, tobacco smoke which is a key factor in the development and progression of COPD. COPD was considered the third leading cause of death in U.S. in 2017, with almost 6% of Americans diagnosed with the disease.

Global Respiratory Inhalers Scope and Market Size

Respiratory Inhalers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Inhalers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The following players are covered in this report:

  • Adherium limited
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • Chiesi Farmaceutici S.p.A.
  • GSK plc.
  • Propeller Health
  • Teva Pharmaceutical Industries Ltd.
  • Others

Respiratory Inhalers Breakdown Data by Type

  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Others

Respiratory Inhalers Breakdown Data by Application

  • Asthma
  • COPD
  • Other
TABLE OF CONTENT
LIST OF TABLES & FIGURES

 

 

Respiratory Inhalers Market Overview

The global Respiratory Inhalers market size is projected to reach USD 29220 million by 2026, from USD 28800 million in 2020, at a CAGR of 1.3%% during 2021-2026.

Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. To counter these respiratory disorders, scientists have developed various drugs and devices. Extensive efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder which affects the majority of the patients.

Globally North America is the largest market for Respiratory Inhalers accounting 35.1% of the total market. This large share is majorly due to, tobacco smoke which is a key factor in the development and progression of COPD. COPD was considered the third leading cause of death in U.S. in 2017, with almost 6% of Americans diagnosed with the disease.

Global Respiratory Inhalers Scope and Market Size

Respiratory Inhalers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Inhalers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The following players are covered in this report:

  • Adherium limited
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • Chiesi Farmaceutici S.p.A.
  • GSK plc.
  • Propeller Health
  • Teva Pharmaceutical Industries Ltd.
  • Others

Respiratory Inhalers Breakdown Data by Type

  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Others

Respiratory Inhalers Breakdown Data by Application

  • Asthma
  • COPD
  • Other
Read More
TABLE OF CONTENT
Read More
LIST OF TABLES & FIGURES

 

 
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Multi User

Electronic (PDF)
$7800
This license allows multiple user to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global Orthopedic Implant Antibacterial Coatings Surface Treatment Market Insights and Forecast to 2026
Global Orthopedic Implant Antibacterial Coatings Surface Treatment Market Insights and Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-28U2969
Tue Aug 04 00:00:00 UTC 2020

Add to Cart

Global Medical Ultrasonic Baths Market Insights and Forecast to 2026
Global Medical Ultrasonic Baths Market Insights and Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-5V3313
Tue Aug 04 00:00:00 UTC 2020

Add to Cart

Global Interventional Device Market Size Status and Forecast 2020 2026
Global Interventional Device Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-10O3264
Tue Aug 04 00:00:00 UTC 2020

Add to Cart

Global Orthodontic Equipment and Consumables Market Insights and Forecast to 2026
Global Orthodontic Equipment and Consumables Market Insights and Forecast to 2026

120 Pages
Type: Report
Code: QYRE-Auto-11A3307
Tue Aug 04 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0